Suppr超能文献

相似文献

1
Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production.
Neurobiol Dis. 2008 Mar;29(3):422-37. doi: 10.1016/j.nbd.2007.10.005. Epub 2007 Nov 4.
5
The adipocyte differentiation protein APMAP is an endogenous suppressor of Aβ production in the brain.
Hum Mol Genet. 2015 Jan 15;24(2):371-82. doi: 10.1093/hmg/ddu449. Epub 2014 Sep 1.
8
ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production.
PLoS One. 2016 May 19;11(5):e0155400. doi: 10.1371/journal.pone.0155400. eCollection 2016.

引用本文的文献

2
Inhibition of Aβ Aggregation by Cholesterol-End-Modified PEG Vesicles and Micelles.
Pharmaceutics. 2024 Dec 24;17(1):1. doi: 10.3390/pharmaceutics17010001.
3
Lipids and α-Synuclein: adding further variables to the equation.
Front Mol Biosci. 2024 Aug 12;11:1455817. doi: 10.3389/fmolb.2024.1455817. eCollection 2024.
4
Cholesterol and oxysterols in retinal neuron-glia interactions: relevance for glaucoma.
Front Ophthalmol (Lausanne). 2024 Jan 3;3:1303649. doi: 10.3389/fopht.2023.1303649. eCollection 2023.
5
The Intersection of cerebral cholesterol metabolism and Alzheimer's disease: Mechanisms and therapeutic prospects.
Heliyon. 2024 Apr 30;10(9):e30523. doi: 10.1016/j.heliyon.2024.e30523. eCollection 2024 May 15.
6
A Novel Perspective on PCSK9 in Alzheimer's Disease: A Focus on Amyloid Beta.
Curr Med Chem. 2024 Feb 16. doi: 10.2174/0109298673269288231123095215.
7
Cholesterol and COVID-19-therapeutic opportunities at the host/virus interface during cell entry.
Life Sci Alliance. 2024 Feb 22;7(5). doi: 10.26508/lsa.202302453. Print 2024 May.
8
Converged avenues: depression and Alzheimer's disease- shared pathophysiology and novel therapeutics.
Mol Biol Rep. 2024 Jan 28;51(1):225. doi: 10.1007/s11033-023-09170-1.
9
Flavonoids and fibrate modulate apoE4-induced processing of amyloid precursor protein in neuroblastoma cells.
Front Neurosci. 2023 Dec 22;17:1245895. doi: 10.3389/fnins.2023.1245895. eCollection 2023.

本文引用的文献

3
PPARgamma agonists as new therapeutic agents for the treatment of Alzheimer's disease.
Exp Neurol. 2006 Jun;199(2):245-8. doi: 10.1016/j.expneurol.2006.04.006. Epub 2006 May 30.
4
Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease.
Neurobiol Aging. 2007 Jun;28(6):856-62. doi: 10.1016/j.neurobiolaging.2006.04.005. Epub 2006 May 24.
5
The involvement of lipid rafts in Alzheimer's disease.
Mol Membr Biol. 2006 Jan-Feb;23(1):111-22. doi: 10.1080/09687860500496417.
6
Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures.
J Neuroimmunol. 2006 May;174(1-2):63-73. doi: 10.1016/j.jneuroim.2006.01.014. Epub 2006 Feb 28.
7
Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18700-5. doi: 10.1073/pnas.0508693102. Epub 2005 Dec 12.
8
Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.
J Biol Chem. 2005 Dec 30;280(52):43224-35. doi: 10.1074/jbc.M504513200. Epub 2005 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验